Silex Systems Limited Publishes Investor Presentation on Commercialising Next-Generation Laser Uranium Enrichment Technology

Reuters
02/25
<a href="https://laohu8.com/S/SLX.AU">Silex Systems</a> Limited Publishes Investor Presentation on Commercialising Next-Generation Laser <a href="https://laohu8.com/S/UEC">Uranium</a> Enrichment Technology

Silex Systems Limited released an investor presentation outlining progress on commercialising its SILEX laser-based uranium enrichment technology through its US joint venture Global Laser Enrichment $(GLE)$, which is owned 51 percent by Silex and 49 percent by Cameco. The presentation notes that a large-scale technology demonstration at Technology Readiness Level 6 was completed in October 2025, and that TRL-7 and Manufacturing Readiness Level 7 activities are underway to support final equipment designs and supply chain development. The presentation also describes GLE’s planned Paducah Laser Enrichment Facility in Kentucky, including a project to process US Department of Energy depleted uranium tails inventories for uranium and conversion output, alongside potential enrichment services for LEU, LEU+ and HALEU. It states that the US Nuclear Regulatory Commission accepted GLE’s licence application for the facility in August 2025, and that GLE was selected for a US Department of Energy award of up to US$28.5 million in January 2026. You can access the full presentation through the link below. https://www.silex.com.au

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silex Systems Limited published the original content used to generate this news brief on February 24, 2026, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10